pyrazines has been researched along with Lichen Myxedematosus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hummers, LK | 1 |
| Arpaci, F; Ataergin, S; Demiriz, M; Ozet, A | 1 |
| Dimopoulos, MA; Gkotzamanidou, M; Kastritis, E; Migkou, M; Terpos, E | 1 |
| Dalmau, J; Fett, NM; Shinohara, MM; Toporcer, MB; Vogl, DT | 1 |
| Cañueto, J; Contreras, T; García-Sanz, R; Gutiérrez, NC; Labrador, J; Román, C; Santos-Briz, A | 1 |
| Kwong, YL; Loong, F; Yeung, CK | 1 |
1 review(s) available for pyrazines and Lichen Myxedematosus
| Article | Year |
|---|---|
Scleromyxedema.
Topics: Boronic Acids; Bortezomib; Humans; Immunoglobulins, Intravenous; Pyrazines; Scleromyxedema; Thalidomide; Treatment Outcome | 2014 |
5 other study(ies) available for pyrazines and Lichen Myxedematosus
| Article | Year |
|---|---|
Transient efficacy of double high-dose chemotherapy and autologous peripheral stem cell transplantation, immunoglobulin, thalidomide, and bortezomib in the treatment of scleromyxedema.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Therapy, Combination; Humans; Immunoglobulins; Male; Peripheral Blood Stem Cell Transplantation; Pyrazines; Recurrence; Scleromyxedema; Thalidomide | 2008 |
Response to bortezomib of a patient with scleromyxedema refractory to other therapies.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Immunosuppressive Agents; Male; Pyrazines; Salvage Therapy; Scleromyxedema; Treatment Outcome | 2011 |
Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Scleromyxedema | 2011 |
The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Female; Humans; Pyrazines; Scleromyxedema | 2012 |
Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Dexamethasone; Female; Humans; Middle Aged; Neoplasms, Plasma Cell; Pyrazines; Scleromyxedema; Thalidomide | 2012 |